Although, in patients undergoing BTKi therapy, a positive TP53 status was strongly linked to disease progression, multivariate analysis indicated a similar trend toward significance, but the limited cohort size prevented it from reaching statistical significance [ 40 ].
← all excerpts
Waldenström Macroglobulinemia: The Role of TP53 Mutations in Disease Progression and Therapeutic Response.
1
—
—